CN1164613C - 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 - Google Patents
简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 Download PDFInfo
- Publication number
- CN1164613C CN1164613C CNB001072986A CN00107298A CN1164613C CN 1164613 C CN1164613 C CN 1164613C CN B001072986 A CNB001072986 A CN B001072986A CN 00107298 A CN00107298 A CN 00107298A CN 1164613 C CN1164613 C CN 1164613C
- Authority
- CN
- China
- Prior art keywords
- milliliters
- hdl
- density lipoprotein
- precipitation agent
- test kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010010234 HDL Lipoproteins Proteins 0.000 title claims abstract description 48
- 102000015779 HDL Lipoproteins Human genes 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 17
- 239000003153 chemical reaction reagent Substances 0.000 title abstract description 6
- 210000002966 serum Anatomy 0.000 title abstract description 6
- 230000008569 process Effects 0.000 title abstract description 3
- 238000001556 precipitation Methods 0.000 claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 229960000633 dextran sulfate Drugs 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000005457 ice water Substances 0.000 claims abstract description 3
- 239000002244 precipitate Substances 0.000 claims abstract description 3
- 239000000376 reactant Substances 0.000 claims abstract description 3
- 238000005070 sampling Methods 0.000 claims abstract description 3
- 150000002148 esters Chemical class 0.000 claims abstract 3
- 238000012360 testing method Methods 0.000 claims description 26
- 238000000926 separation method Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000013016 damping Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003729 cation exchange resin Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 210000003739 neck Anatomy 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- 150000008065 acid anhydrides Chemical class 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 abstract description 8
- 229920002307 Dextran Polymers 0.000 abstract description 5
- 229960002086 dextran Drugs 0.000 abstract description 5
- 102000004895 Lipoproteins Human genes 0.000 abstract description 3
- 108090001030 Lipoproteins Proteins 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000006172 buffering agent Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 30
- 238000011160 research Methods 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005199 ultracentrifugation Methods 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- -1 acid anhydride ester Chemical class 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 108010021075 HDL2 Lipoproteins Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000008604 lipoprotein metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
- 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法。其特征在于:分两大步制作:一、先简便快速合成特定低分子量右旋糖酐硫酸酯,其方法为:1、取2000毫升圆底三口烧瓶置于冰水浴中,加入525毫升甲酰胺溶液,并不断搅拌使溶液温度低至10℃以下:2、在维持内温在15℃以下的情况滴加125毫升氯磺酸:至滴完;3、逐渐升温至50-52℃,之后加干燥的分子量为25,000的氢化右旋糖酐50克,并不断搅拌和控制内温在50-52℃之间,一小时后取样测定反应物的粘度当比粘度在0.65±0.05范围时应中止反应;4、冷却至30℃以下时加入1000毫升98%以上的乙醇进行沉淀,放置半小时后,倾去上清液,再将沉淀物溶解于300毫升蒸馏水中,再加800毫升98%乙醇沉淀一次,之后将沉淀物溶解于250毫升蒸馏水中,并调节PH至9搅拌1小时,再将溶液通过阳离子交换树脂柱以除去杂质之后过滤将滤液的PH调至7,即可沉淀干燥成白色粉状的右旋糖酐硫酸酯;
- 二、制作分离高密度脂蛋白及其组分试剂盒:本试剂盒由沉淀剂I和沉淀剂II组成1、分离高密度脂蛋白的沉淀剂I:将由组分右旋糖酐硫酸酯1.25%、氯化镁10.5%和0.5Mtris-HCL缓冲液0.1%组成的沉淀剂I的4毫升浓缩液加在每个洁净的10毫升的小玻璃瓶中,然后真空干燥加盖密封;2、分离高密度脂蛋白亚组分的沉淀剂II将由组分右旋糖酐硫酸酯0.95%、氯化镁20%,0.5M Tris-HCL缓冲液0.1%组成的沉淀剂II的4毫升加在每个洁净的10毫升小玻璃瓶中然后真空干燥加盖密封。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001072986A CN1164613C (zh) | 2000-05-09 | 2000-05-09 | 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001072986A CN1164613C (zh) | 2000-05-09 | 2000-05-09 | 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1322731A CN1322731A (zh) | 2001-11-21 |
CN1164613C true CN1164613C (zh) | 2004-09-01 |
Family
ID=4578602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001072986A Expired - Lifetime CN1164613C (zh) | 2000-05-09 | 2000-05-09 | 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1164613C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100457774C (zh) * | 2005-06-03 | 2009-02-04 | 陈允钦 | 凝胶电泳分离血清脂蛋白及其量化检测的新方法 |
EP3220144B1 (en) * | 2010-02-26 | 2018-11-28 | Sekisui Medical Co., Ltd. | Blood separating agent and blood collection container |
CN109580303A (zh) * | 2018-12-06 | 2019-04-05 | 潍坊泽成生物技术有限公司 | 低密度脂蛋白的制备方法 |
-
2000
- 2000-05-09 CN CNB001072986A patent/CN1164613C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1322731A (zh) | 2001-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Beisswenger et al. | Studies on the human glomerular basement membrane: composition, nature of the carbohydrate units and chemical changes in diabetes mellitus | |
US6048903A (en) | Treatment for blood cholesterol with trans-resveratrol | |
Rapport et al. | Analysis of the Products Formed on Hydrolysis of Hyaluronic Acid by Testicular Hyaluronidase1, 2 | |
Fischer et al. | Fluorescence of. DELTA. 5, 7, 9 (11), 22-ergostatetraen-3. beta.-ol in micelles, sterol carrier protein complexes, and plasma membranes | |
CN108362881B (zh) | 一种吡唑酮类解热镇痛药物的胶体金快速检测试装置及其制备方法和用途 | |
CN1164613C (zh) | 简便分离血清高密度脂蛋白及其亚组分试剂盒的制备方法 | |
CN112441952A (zh) | 一种大麻二酚-3-磺酸及其制备方法和应用、大麻二酚衍生物 | |
Collman et al. | The chemistry of metal chelate rings. IV. Electrophilic substitution of optically active tris-acetylacetonates | |
EP0460576B1 (en) | Assay for cobalamins | |
US5506221A (en) | Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents | |
US8129363B2 (en) | Method for obtaining conjugated estrogen mixtures from pregnant mare urine and use of a macroporous resin in the method | |
CN113105522B (zh) | 一种泽泻三萜类化合物及其制备方法、结构表征方法和应用 | |
CN1323081C (zh) | 二步树脂法制备河豚毒素的方法及河豚毒素制剂 | |
McGandy et al. | Crystal and molecular structure of N-methyl-N-tert-butyl-3-hydroxyazetidinium methanesulfonate, a nonplanar azetidinium ring | |
Dickinson et al. | Rearrangement of Valproate Glucuronide in a Patient with Drug‐Associated Hepatobiliary and Renal Dysfunction | |
Katsura et al. | Plasma levels of leukotriene C4, B4 slow reacting substance of anaphylaxis in chloronological phases of cerebrovascular disease | |
CN111217873A (zh) | 一种倍半萜苷单体化合物及其制备方法与应用 | |
CN114075198B (zh) | 一种新型黄芪生物碱及其在治疗神经退行性疾病中的应用 | |
CN112159439B (zh) | 紫杉氰糖苷类化合物及其制备方法和应用 | |
Winter | The nature of the blood-sugar | |
Crist et al. | Chair-boat conformational equilibrium in (+)-(1S, 5R)-1, 8, 8-trimethylbicyclo [3.2. 1] octan-3-one | |
CN1164743C (zh) | 从甘蔗的嫩叶中提取过氧化物酶的方法 | |
CN117003811A (zh) | 一种甾体化合物及其在治疗神经退行性疾病中的应用 | |
Bell et al. | The interaction of D-penicillamine with aldehydes and ketones: 2-phenyl-5, 5-dimethylthiazolidine-4-carboxylic acid | |
CN118206612A (zh) | 一种Ocotillol型皂苷元A环并氨基噻唑环衍生物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HERBON INTERNATIONAL POLYSACCHARIDE BIOTECHNOLOGY Free format text: FORMER OWNER: ZHUANG MAO Effective date: 20120705 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100832 NO.34, FUWAI AVENUE, BEIJING CITY TO: 517000 NO.22-5, LONGLING INDUSTRIAL PARK, YUANCHENG DISTRICT, HEYUAN CITY, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120705 Address after: 517000 Guangdong Yuancheng District Heyuan City, Long Ridge Industrial Park No. 22-5 Patentee after: Herbon international polysaccharide biological technology (Heyuan) Co., Ltd. Address before: 100832 Beijing Fuwai Street No. 34 Patentee before: Zhuang Mao Effective date of registration: 20120705 Address after: 517000 Guangdong Yuancheng District Heyuan City, Long Ridge Industrial Park No. 22-5 Patentee after: Herbon international polysaccharide biological technology (Heyuan) Co., Ltd. Address before: 100832 Beijing Fuwai Street No. 34 Patentee before: Zhuang Mao |
|
CX01 | Expiry of patent term |
Granted publication date: 20040901 |
|
CX01 | Expiry of patent term |